Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Die Pharmazie|January 10, 2006
Alkaloids of Haloxylon salicornicum (Moq.) Bunge ex Boiss. (Chenopodiaceae)A M El-Shazly, G Dora, M WinkCarbohydrate Polymers|February 13, 2013
Biocomposite from polylactic acid and lignocellulosic fibers: structure-property correlationsG Faludi, G Dora, K Renner, et al.Vaccine|May 4, 2019
An adjuvanted adenovirus 5-based vaccine elicits neutralizing antibodies and protects mice against chikungunya virus-induced footpad swellingEmery G Dora, Shannan L Rossi, Scott C Weaver, et al.Current Genetics|March 18, 1999
RPD3 (REC3) mutations affect mitotic recombination in Saccharomyces cerevisiaeE G Dora, N Rudin, J R Martell, et al.Frontiers in Immunology|March 13, 2023
Mucosal immunization with Ad5-based vaccines protects Syrian hamsters from challenge with omicron and delta variants of SARS-CoV-2Molly R Braun, Clarissa I Martinez, Emery G Dora, et al.Vaccines|September 28, 2024
Elimination of Human Papillomavirus 16-Positive Tumors by a Mucosal rAd5 Therapeutic Vaccination in a Pre-Clinical Murine StudyMolly R Braun, Anne C Moore, Jonathan D Lindbloom, et al.Vaccines|February 24, 2024
A Next-Generation Adenoviral Vaccine Elicits Mucosal and Systemic Immunogenicity and Reduces Viral Shedding after SARS-CoV-2 Challenge in Nonhuman PrimatesSarah N Tedjakusuma, Colin A Lester, Elena D Neuhaus, et al.The Journal of Infectious Diseases|November 10, 2021
Oral Vaccination Protects Against Severe Acute Respiratory Syndrome Coronavirus 2 in a Syrian Hamster Challenge ModelSusan Johnson, Clarissa I Martinez, Sarah N Tedjakusuma, et al.Science Translational Medicine|May 5, 2022
Adenovirus type 5 SARS-CoV-2 vaccines delivered orally or intranasally reduced disease severity and transmission in a hamster modelStephanie N Langel, Susan Johnson, Clarissa I Martinez, et al.Nature Medicine|January 12, 2021
Modeling human adaptive immune responses with tonsil organoidsLisa E Wagar, Ameen Salahudeen, Christian M Constantz, et al.Pageof 1